|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300078885 |
|
最近更新日期: Date of Last Refreshed on: |
2023-12-20 15:28:36 |
|
注册时间: Date of Registration: |
2023-12-20 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中国居民身心共病队列调查研究 |
|
Public title: |
A cohort study of psychosomatic comorbidities among Chinese residents |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中国居民身心共病队列调查研究 |
|
Scientific title: |
A cohort study of psychosomatic comorbidities among Chinese residents |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
扶蓉 |
研究负责人: |
何飞英 |
|
Applicant: |
FuRong |
Study leader: |
He Feiying |
|
申请注册联系人电话: Applicant telephone: |
+86 147 1414 9557 |
研究负责人电话:
Study leader's |
+86 136 3210 1561 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
2392809087@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
361439830@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省广州市白云区沙太南路南方医科大学 |
研究负责人通讯地址: |
广东省广州市白云区沙太南路南方医科大学 |
|
Applicant address: |
Southern Medical University, Shatai South Road, Baiyun District, Guangzhou City, Guangdong Province |
Study leader's address: |
Southern Medical University, Shatai South Road, Baiyun District, Guangzhou City, Guangdong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
南方医科大学 |
||
|
Applicant's institution: |
Southern Medical University |
||
|
研究负责人所在单位: |
南方医科大学 |
||
|
Affiliation of the Leader: |
Southern Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
南医伦审[2023]第86号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南方医科大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Ethics Committee, Southern Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-01 00:00:00 | ||
|
伦理委员会联系人: |
王颖锋 |
||
|
Contact Name of the ethic committee: |
Wang Yingfeng |
||
|
伦理委员会联系地址: |
广东省广州市白云区沙太南路南方医科大学 |
||
|
Contact Address of the ethic committee: |
Southern Medical University, Shatai South Road, Baiyun District, Guangzhou City, Guangdong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 137 6063 5685 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
南方医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Southern Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省广州市白云区沙太南路南方医科大学 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Southern Medical University, Shatai South Road, Baiyun District, Guangzhou City, Guangdong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
南方医科大学 |
||||||||||||||||||||||
|
Source(s) of funding: |
Southern Medical University |
||||||||||||||||||||||
|
研究疾病: |
慢性病及慢性病共病 |
||||||||||||||||||||||
|
Target disease: |
Chronic diseases and chronic comorbidities |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
流行病学研究 |
||||||||||||||||||||||
|
Study type: |
Epidemilogical research |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
通过调查问卷、体检生化数据和肠道菌群检测的方法,了解中国居民的心理及健康相关行为的概况,为“健康中国”策略的推进提供依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
By means of questionnaires, physical examination biochemical data and intestinal flora detection, the psychological and health-related behaviors of Chinese residents were understood, providing a basis for the promotion of the "Healthy China" strategy. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
不适用 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
Not Applicable |
||||||||||||||||||||||
|
纳入标准: |
①年龄≥12岁; ②具有中华人民共和国国籍; ③中国常住人口(年累计出境时间≤1个月); ④自愿参加研究,填写知情同意书; ⑤可自行完成网络问卷调查或在调查员帮助下完成问卷调查; ⑥了解问卷每个条目所表达的含义。 |
||||||||||||||||||||||
|
Inclusion criteria |
① ≥12 years old; ②Having the nationality of the People's Republic of China; ③China's permanent resident population (annual cumulative outbound time≤1 month); ④ Volunteer to participate in the study and fill in the informed consent; ⑤ can complete the online questionnaire survey or complete the questionnaire survey with the help of the investigator; ⑥ Understand the meaning of each item in the questionnaire. |
||||||||||||||||||||||
|
排除标准: |
①神志不清、精神异常者; ②正在参加其他类似研究课题者; ③不愿合作者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
① Individuals with confusion or mental abnormalities; ② Participants in other similar research projects; ③ Unwilling collaborators. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-12-01 00:00:00至 To 2029-06-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-01-01 00:00:00 至 To 2029-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究抽样方法采用多层随机抽样。首先将中国23个省和5个自治区、4个直辖市直接纳入,用随机数表法在每个省(自治区、直辖市)的非省会地级行政区中各抽取2-4个城市,共71个城市;随后,用随机数表法在抽取的城市中分别抽取12-24个农村社区共426个、8-16个城镇社区共284个,合计710个社区。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The sampling method used in this study is multi-layer random sampling. Firstly, 23 provinces, 5 autonomous regions, and 4 municipalities directly under the central government of China will be directly included. Using a random number table method, 2-4 cities will be selected from each province (autonomous region, municipality)'s non provincial capital level administrative region, totaling 71 cities; Subsequently, a random number table method was used to select a total of 426 rural communities and 284 urban communities from 12-24 rural communities and 8-16 urban communities in the selected cities, totaling 710 communities. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不适用 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not Applicable |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
不适用 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Not Applicable |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |